Exane Derivatives Cooper Companies, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Cooper Companies, Inc. stock. As of the latest transaction made, Exane Derivatives holds 9 shares of COO stock, worth $868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 63
85.71%
Holding current value
$868
Previous $26,000
92.31%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding COO
# of Institutions
45Shares Held
1.59MCall Options Held
0Put Options Held
0-
Intermede Investment Partners LTD1.09MShares$106 Million2.52% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8143KShares$13.8 Million0.07% of portfolio
-
Brant Point Investment Management LLC New York, NY109KShares$10.5 Million2.96% of portfolio
-
Eaton Vance Management Boston, MA86.1KShares$8.31 Million0.03% of portfolio
-
Crystal Rock Capital Management54.2KShares$5.23 Million3.65% of portfolio
About COOPER COMPANIES, INC.
- Ticker COO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 49,346,000
- Market Cap $4.76B
- Description
- The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...